| Clinical and prognostic significance of coagulation assays in lung cancer F Tas, L Kilic, M Serilmez, S Keskin, F Sen, D Duranyildiz Respiratory medicine 107 (3), 451-457, 2013 | 118 | 2013 |
| Prognostic factors in metastatic pancreatic cancer: Older patients are associated with reduced overall survival F Tas, F Sen, S Keskin, L Kilic, I Yildiz Molecular and clinical oncology 1 (4), 788-792, 2013 | 69 | 2013 |
| Noncutaneous melanoma have distinct features from each other and cutaneous melanoma F Tas, S Keskin, A Karadeniz, N Dağoğlu, F Sen, L Kilic, I Yildiz Oncology 81 (5-6), 353-358, 2012 | 68 | 2012 |
| Obezite ve inflamasyon S KESKİN, E SAYALI, E TEMELOĞLU, İ EKİZOĞLU Turkiye klinikleri journal of medical sciences 25 (5), 636-641, 2005 | 56 | 2005 |
| Clinical and prognostic significance of coagulation assays in advanced epithelial ovarian cancer F Tas, L Kilic, E Bilgin, S Keskin, F Sen, R Ciftci, I Yildiz, V Yasasever International Journal of Gynecologic Cancer 23 (2), 2013 | 47 | 2013 |
| Induction chemotherapy with docetaxel and cisplatin is highly effective for locally advanced nasopharyngeal carcinoma M Ekenel, S Keskin, M Basaran, C Ozdemir, R Meral, M Altun, I Aslan, ... Oral oncology 47 (7), 660-664, 2011 | 40 | 2011 |
| Abundant circulating microRNAs in breast cancer patients fluctuate considerably during neoadjuvant chemotherapy U Gezer, S Keskin, A İğci, M Tükenmez, D Tiryakioğlu, M Cetinkaya, ... Oncology letters 8 (2), 845-848, 2014 | 35 | 2014 |
| D-dimer and international normalized ratio (INR) are correlated with tumor markers and disease stage in colorectal cancer patients L Kilic, I Yildiz, FK Sen, MG Erdem, M Serilmez, S Keskin, R Ciftci, ... Cancer Biomarkers 15 (4), 405-411, 2015 | 31 | 2015 |
| High serum transforming growth factor beta 1 (TGFB1) level predicts better survival in breast cancer R Ciftci, F Tas, CT Yasasever, E Aksit, S Karabulut, F Sen, S Keskin, ... Tumor Biology 35, 6941-6948, 2014 | 29 | 2014 |
| Mucosal melanoma in the head and neck region: different clinical features and same outcome to cutaneous melanoma F Tas, S Keskin International Scholarly Research Notices 2013, 2013 | 29 | 2013 |
| Current adjuvant treatment modalities for gastric cancer: from history to the future L Kilic, C Ordu, I Yildiz, F Sen, S Keskin, R Ciftci, KN Pilanci World journal of gastrointestinal oncology 8 (5), 439, 2016 | 28 | 2016 |
| Türkiye’de meme kanserli hastaların tanı ve tedavi yöntemlerine ulaşım hızı; çok merkezli gözlemsel çalışma P Saip, S Keskin, M Özkan, MA Kaplan, F Aydoğan, GG Demirağ, ... The Journal of Breast Health 7 (3), 109-117, 2011 | 27 | 2011 |
| Effect of increased body mass index (BMI) on time to tumour progression (TTP) in unresectable metastatic colorectal cancer (mCRC) patients treated with bevacizumab-based therapy N Faruk Aykan, I Yildiz, F Sen, L Kilic, S Keskin, R Ciftci, S Karabulut, ... Medical Oncology 30, 1-6, 2013 | 26 | 2013 |
| Clinical and pathological features of breast cancer associated with the pathological complete response to anthracycline-based neoadjuvant chemotherapy S Keskin, M Muslumanoglu, P Saip, H Karanlık, M Guveli, E Pehlivan, ... Oncology 81 (1), 30-38, 2011 | 26 | 2011 |
| Favorable survival time provided with radioembolization in hepatocellular carcinoma patients with and without portal vein thrombosis ZG Ozkan, A Poyanli, A Ucar, S Kuyumcu, F Akyuz, S Keskin, S Saglam, ... Cancer Biotherapy and Radiopharmaceuticals 30 (3), 132-138, 2015 | 25 | 2015 |
| The major stressful life events and cancer: stress history and cancer F Tas, U Karalar, M Aliustaoglu, S Keskin, G Can, FE Cinar Medical Oncology 29, 1371-1377, 2012 | 25 | 2012 |
| Clinical and prognostic significance of coagulation assays in melanoma F Tas, R Ciftci, L Kilic, E Bilgin, S Keskin, F Sen, I Yildiz, V Yasasever Melanoma research 22 (5), 368-375, 2012 | 20 | 2012 |
| Fama-French çok faktör varlık fiyatlama modellerinin performanslarının karşılaştırılması: Borsa İstanbul üzerine bir uygulama G Aras, İ Çam, B Zavalsız, S Keskin Istanbul business research 47 (2), 183-207, 2018 | 18 | 2018 |
| Predictive role of midtreatment changes in survivin, GSTP1, and topoisomerase 2α expressions for pathologic complete response to neoadjuvant chemotherapy in patients with … Y Eralp, S Keskin, E Akisik, E Akisik, A Igci, M Müslümanoglu, S Yilmaz, ... American journal of clinical oncology 36 (3), 215-223, 2013 | 18 | 2013 |
| Clinicopathological characteristics and treatment outcomes of adult patients with paratesticular rhabdomyosarcoma (PRMS): A 10-year single-centre experience S Keskin, M Ekenel, M Basaran, I Kilicaslan, M Tunc, S Bavbek Canadian Urological Association Journal 6 (1), 42, 2012 | 18 | 2012 |
